New vaccine slashes chance of melanoma patients’ tumors returning, study shows
Posted
Personalized Moderna and Merck vaccine, called intismeran, was made with same Nobel Prize-winning mRNA technology behind COVID-19 vaccines
Keywords
Israel & the Region, melanoma, Moderna, Merck, cancer, vaccines, cancer research
published by
